Search Results for “Customizable SAP E_S4HCON2023 Practice Exam Software 🐂 Easily obtain ➠ E_S4HCON2023 🠰 for free download through ⇛ www.pdfvce.com ⇚ 🛐E_S4HCON2023 Exam Practice” – Page 23

Travel-associated infectious skin diseases

160.

Rongisch, R., Schmidt, E., Deresz, N., Deresz, K., Schöfer, H., Just-Nübling, G., Schäkel, K., Jakob, T., Maurer, M., Sticherling, M., Sunderkötter, C., Babilas, P., Spornraft-Ragaller, P., Traidl-Hoffmann, C., Gläser, R., Hartmann, K., Kolb-Mäurer, A., Wenzel, J., Biedermann, T., Homey, B., Pfützner, W., Weid, F., Fischer, M., Linder, R., and von Stebut, E.⁺: Travel-associated infectious skin diseases. J. Dtsch. Dermatol. Ges. 2020: 18; 730-733. IF: 5.58

r.160

383.	Altrichter, S., Schumacher, P., Alraboni, O., Wang, Y., Hiragun, M., Hide, M., and Maurer, M.⁺: Sensitization against skin resident fungi is associated with atopy in cholinergic urticaria patients. Clin. Transl. Allergy 2020: 10; 18. IF: 5.87

o.383

271	Krause, K., Tsianakas, A., Wagner, N., Fischer, J., Weller, K., Metz, M., Church, M. K., and Maurer, M.:Efficacy and safety of canakinumab in Schnitzler syndrome: a multicenter randomized placebo-controlled study. J. Allergy Clin. Immunol. 2017: 139; 1311-1320. IF: 13.26

416.	Matanis, L., Eiza, N., Sabag, A., Bejar, J., Giménez-Arnau, A. M., Maurer, M., and Vadasz, Z.⁺: The expression of IL-17, in chronic spontaneous urticaria is linked to semaphorin5A. Biomolecules 2021: 11; 373. IF: 6.06

o.416

418.	Türk, M., Yilmaz, I., Hawro, T., and Maurer, M.⁺: Worsening of chronic spontaneous urticaria after intake of hot pepper. Asian Pac. J. Allergy Immunol. 2021: 39; 25-30. IF: 7.14

o.418

159	Nullens, S., Sabato, V., Faber, M., Leysen, J., Bridts, C. H., de Clerck, L. S., Falcone, F., Maurer, M.and Ebo, D. G.+: Basophilic histamine content and release during venom immunotherapy: insights by flow cytometry. Cytom. Part B – Clin. CY 2013: 84; 173-178. IF: 2.28

322	Hawro, T., Ohanyan, T., Schoepke, N., Metz, M., Peveling-Oberhag, A., Staubach, P., Maurer, M. and Weller, K.+: The urticaria activity score – validity, reliability, and responsiveness. J. Allergy Clin. Immunol. Pract. 2018: 6; 1185-1190. IF: 7.55

A novel histopathological scoring system to distinguish urticarial vasculitis from chronic spontaneous urticaria

430.

Puhl, V., Bonnekoh, H., Scheffel, J., Hawro, T., Weller, K., von den Driesch, P., Röwert-Huber, H.-J., Cardoso, J., Gonçalo, M., Maurer, M., and Krause, K.⁺: A novel histopathological scoring system to distinguish urticarial vasculitis from chronic spontaneous urticaria. Clin. Transl. Allergy 2021: 11; e12031. IF: 5.66

o.430

Substance P as an Immunomodulatory Neuropeptide in a Mouse Model for Autoimmune Hair Loss (Alopecia Areata)

Siebenhaar, F., Sharov, A. A., Peters, E. M. J., Sharova, T. Y., Syska, W., Mardaryev, A. N., Freyschmidt-Paul, P., Sundberg, J. P., Maurer, M. and Botchkarev, V. A.+: Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (Alopecia Areata). J. Invest. Dermatol. 2007: 127; 1489-1497. IF: 4.83

38.	Krause, K., Zuberbier, T. and Maurer, M.: Modern approaches to the diagnosis and treatment of cold contact urticaria. Curr. Allergy Asthm. 2010: 10; 243-249. IF: 2.34

Results